Pathophysiologic Approach News Today

Lecanemab is a humanized immunoglobulin gamma 1 monoclonal antibody that targets amyloid plaques, which are thought to play a role in the development and progression of Alzheimer disease.

Patients often turn to dietary supplements for the management of osteoarthritis, one of which is turmeric.

Sarah Lynch’s profile on The Conversation

The estimated cost burden of schizophrenia is more than $150 billion, consisting of direct treatment cost and lost productivity.